No Data
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Medtronic (MDT) Receives a Buy From RBC Capital
Healing People and Planet: New Impact Report Outlines How Medtronic Is Shaping the Future of Health
SA Charts: These S&P 500 Companies Spent the Largest on Buybacks Last Quarter
Wells Fargo Maintains Overweight on Medtronic, Lowers Price Target to $98
Artificial Intelligence (AI) Reshaping Healthcare Industry With Unimaginable Potential